COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,755 Articles (22,502 medRxiv, 8,253 bioRxiv)

Most recent first Previous |  Page 1100: Articles 10991-11000  | Next

Use cases for COVID-19 screening and surveillance with rapid antigen-detecting tests: a systematic review
Anand, A., Bigio, J., MacLean, E., Underwood, T., Pant Pai, N., Carmona, S., Schumacher, S. G., Toporowski, A.
10.1101/2021.11.03.21265807 — Posted: 2021-11-03
The basic reproduction number of COVID-19 across Africa
Iyaniwura, S. A., Musa, M. R., David, J. F., Kong, J. D.
10.1101/2021.11.02.21265826 — Posted: 2021-11-03
Effectiveness of COVID-19 Vaccines and Post-vaccination SARS-COV 2 Infection, Hospitalization, and Mortality: a Systematic Review and Meta-analysis of Observational Studies
Rahmani, K., Shavaleh, R., Forouhi, M., Feiz Disfani, H., Kamandi, M., Asareh Zadegan Dezfuli, A., Khatamian Oskooi, R., Foogerdi, M., Soltani, M.
10.1101/2021.11.03.21265819 — Posted: 2021-11-03
Multiplex Solid-Phase RPA Coupled CRISPR-Based Visual Detection of SARS-CoV-2
Qin, X., Zhou, Y., Paul, R., Wu, Y., Liu, Y.
10.1101/2021.11.02.21265831 — Posted: 2021-11-03
Black and Native Overdose Mortality Overtook that of White Individuals During the COVID-19 Pandemic
Friedman, J., Hansen, H.
10.1101/2021.11.02.21265668 — Posted: 2021-11-03
A RCT of a third dose CoronaVac or BNT162b2 vaccine in adults with two doses of CoronaVac
Mok, C. K. P., Cheng, S. M. S., Chen, C., Yiu, K., Chan, T.-O., Lai, K. C., Ling, K. C., Ho, L. L., Peiris, M., Hui, D. S.
10.1101/2021.11.02.21265843 — Posted: 2021-11-03 Discussion: Onsite
mRNA Vaccines Induce Rapid Antibody Responses in Mice
Gebre, M., Rauch, S., Roth, N., Gergen, J., Yu, J., Liu, X., Cole, A., Mueller, S., Petsch, B. W., Barouch, D. H.
10.1101/2021.11.01.466863 — Posted: 2021-11-02
Antiviral activity of Pacific oyster (Crassostrea gigas) hemolymph against a human coronavirus.
Pedler, R. L., Harris, J., Speck, P. G.
10.1101/2021.11.01.466695 — Posted: 2021-11-02
Glycan-masking spike antigen in NTD and RBD elicits broadly neutralizing antibodies against SARS-CoV-2 variants
Lin, W.-S., Chen, I.-C., Chen, H.-C., Lee, Y.-C., Wu, S.-C.
10.1101/2021.11.01.466834 — Posted: 2021-11-02
Germinal centre-driven maturation of B cell response to SARS-CoV-2 vaccination
Kim, W., Zhou, J. Q., Sturtz, A. J., Horvath, S. C., Schmitz, A. J., Lei, T., Kalaidina, E., Thapa, M., Al Soussi, W. B., Haile, A., Klebert, M. K., Suessen, T., Parra-Rodriguez, L., Mudd, P. A., Middleton, W. D., Teefy, S. A., Pusic, I., O'Halloran, J. A., Presti, R. M., Turner, J. S., Ellebedy, A. H.
10.1101/2021.10.31.466651 — Posted: 2021-11-02

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).